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A B S T R A C T
Ictal-related cardiac asystole is supposed to be a risk factor for sudden unexpected death in epilepsy
(SUDEP). We retrospectively analyzed the occurrence of ictal asystole in 2003 epilepsy patients
undergoing long-term video EEG/ECGmonitoring from 1/1999 to 6/2010 at the Freiburg epilepsy centre.
Seven patients had cardiac arrest with a duration of at least 3 s; 6 ictal, one postictal. In all patients, the
temporal lobewas involved in ictal activity based on neurophysiological investigations ormorphological
lesion. Whereas asystole was self-limited in six cases, one patient with insular seizure origin had to
undergo cardiopulmonary resuscitation. Interestingly, also patients with a short history of epilepsy, low
seizure frequency and under treatment in monotherapy showed episodes of asystole. In all cases, even
with brief cardiac arrest, asystole was associated with subsequent EEG ﬂattening.
In conclusion, ictal asystole is a rare event even in a population undergoing major changes in
antiepileptic medication. Temporal lobe epilepsy was associated with a risk for asystole; cardiac arrest
also occurred in patients who, based on their history, might have not been considered at elevated risk for
SUDEP.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The mean incidence of sudden unexpected death in epilepsy
(SUDEP), as one of the risk factors of a premature mortality in
epilepsy patients, is on average about 1.8/1000.1,2 It is elevated
particularly in patients with refractory epilepsy.3 The underlying
pathophysiology is not completely understood but seizure-related
pulmonary oedema, central apnoe, and neurogenic cardiac
asystole are discussed as contributing to SUDEP.4
A prevailing hypothesis is that SUDEP is caused by seizure-
induced cardiorespiratory disturbances, mediated by the auto-
nomic nervous system, with a direct effect on the heart as a
consequence of an imbalance between parasympathetic and
sympathetic activity.5 Seizure-related tachycardia in temporal
lobe epilepsy occurs frequently without clinical consequences,6,7
whereas seizure-related asystole and bradycardia are much less
common.8,9 Ictal bradycardia and asystole have been implicated as
a cardiac cause of SUDEP.10 Many brain stimulation studies
documented the cortical inﬂuence on cardiovascular responses like
heart rate,11 and a number of case reports suggest their clinical
relevance.12,13* Corresponding author. Tel.: +49 761 270 5391; fax: +49 761 270 9335.
E-mail address: michael.lanz@uniklinik-freiburg.de (M. Lanz).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.11.017We here analyzed the incidence of ictal cardiac arrest and
clinical characteristics of patients affected in a large patient cohort.
2. Methods
We retrospectively analyzed the ﬁles of patients withmedically
refractory epilepsy who underwent presurgical or diagnostic video
EEG monitoring between 1999 and 2010 in the Freiburg epilepsy
centre. In each patient, medical history was taken and a
neurological examination was performed before long-term moni-
toring was started. Additionally, the diagnostic protocol included a
comprehensive neuropsychological test battery and high-resolu-
tion brainmagnetic resonance imaging (MRI; Fig. 1). EEG recordings
were performed using surface electrodes placed according to the
international 10–20 system with, when necessary, additional
sphenoidal electrodes and 10–10 electrodes as well as EOG and
ECG coregistration. Invasive electrodes like subdural grids and
strips or depth electrodes were placed individually according to
the hypothesis about the seizure onset zone. EEG data during
video-EEG-monitoring were acquired using video-EEG-systems
from IT-med (Usingen, Germany), or Compumedics (Abbotsford,
Australia). Duringmonitoring, antiepileptic drugs were partially or
totally withdrawn. Video and electrophysiological data from
continuous video EEG/ECG monitoring were analyzed in terms
of semiological phenomena and seizure patterns including region
and lateralization of seizure onset and spread. ECG was analyzedvier Ltd. All rights reserved.
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Fig. 1. MR imaging of the four lesional cases. (a) Multiple subependymal paraventricular heterotopic nodules left ventricle. (b) Hippocampal sklerosis left. (c) DNET left
temporal. (d) Cavernoma insular right.
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tions, and asystoles. Classiﬁcation of epilepsy syndromes and
seizure types was performed according to the criteria of the
international league against epilepsy.14 For inclusion into this
study, a minimum continuous monitoring period of 24 h was
required to be regarded as long-term monitoring.
The work described in this article has been carried out in
accordance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki).
3. Results
2003 patients underwent long-term video-EEG-monitoring in
the years from 1999 to 2010 in Freiburg (1217 for presurgical
evaluation, 786 for syndromatic classiﬁcation and therapy
monitoring). This corresponds to a total of 9534 monitored patient
days.
7 patients (0.34%; 5 female and 2 male, mean age 45.8 years
(range 27–65 years)) suffered an ictal or in one case postictal
(patient 7) asystole during video-EEG-monitoring. Mean onset of
epilepsy was at the age of 25.4 years (range 7–65 years), the mean
duration of epilepsy was 16.4 years (range 1–35 years).
Asystoly occurred early in the course of epilepsy in 2/7 patients
(12 months and 14 months after initial clinical manifestation,
respectively, Table 1).
Syndromatically, all patients suffered from focal epilepsy. Table
2 summarizes the type of epilepsy, the etiology, seizure types and
frequencies, MRI-based localisation of the lesion, EEG ﬁndings andantiepileptic medication. In four out of seven patients, MRI scans
showed lesions (limited to the temporal lobe in patients 4 and 5,
including the temporal lobe but also other regions in patient 1,
located in the right insula in patient 6). Three patients remained
cryptogenic despite the use of dedicated MR protocols including
high-resolution imaging of the temporal region.
EEG recordings obtained during seizures associated with
asystole gave evidence of left temporal seizure onset in two cases
and right temporal seizure onset in three cases. In two cases, early
bilateral activity was recorded, with temporal predominance in
one case (patient 5) and widespread EEG changes in the other
(patient 1). At the time of asystole, however, ictal EEG acitivity had
spread considerably in all cases. In one patient (6) ictal activity
spread from right temporal to left temporal lobe immediately prior
to the occurrence of asystole. Overall, evidence for the involvement
of the temporal lobe was present in all cases of our patient
collective, morphologically and/or electrophysiologically.
Five out of seven patients had been unresponsive to at least two
antiepileptic drug regimens. Four patients were on monotherapy
before video EEG monitoring started, two were under a combina-
tion of two antiepileptic drugs and one patients was treated with
four antiepileptic drugs. At the time of asystole, antiepileptic
medication had been reduced in 4 out of 7 patients; in one of them
AEDs had been completely tapered off (Table 2).
All cases of ictal asystole occurred during a complex partial
seizure. In each case, even in the patient with an asystole lasting
only 3 s, therewas a ﬂattening of electrical brain activity during the
asystole, and loss of muscle tone, at times with myoclonic
[()TD$FIG]
Fig. 2. Onset (a) and end (b) of asystole in patient 6. (c) Beginning and end of resuscitation.
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was started 44 s after the last QRS complex and was successful
after 32 s of cardiac massage. At the time of cardiac arrest, the
seizure lasted 37 s and EEG showed bitemporal rhythmic theta/
delta activity.Table 1
Demographic data.
Patients
1 2
Sex F M
Age (years) 27 41
Age at onset of epilepsy (years) 7 40
Duration of epilepsy before
documented ictal asystole (years)
20 1In one case, bradycardia and in two cases tachyarrythmia was
preceding the asystole, whereas in the other patients ECG had
remained unchanged before asystole.
No patient had interictal clinically relevant cardiac symp-
toms; in one case a left bundle branch block was pre-existing.3 4 5 6 7
F F M F F
47 63 65 55 23
15 62 15 19 20
32 1.2 23 35 3
Table 2
Neurophysiological ﬁndings, MRI and antiepileptic medication.
Patients
1 2 3 4 5 6 7
Type of epilepsy Focal, symptomatic Focal, cryptogenic Focal, cryptogenic Focal, symptomatic Focal, symptomatic Focal, symptomatic Focal, cryptogenic
Etiology Multiple subependymal
paraventricular
heterotopic nodules
Not known Not known DNET Hippocampal sklerosis Cavernoma, Insula¨r right Not known
MRI localisation Left ventricle including
temporal horn
– – Left temporal Left temporal Right insular –
Seizure types SPS SPS SPS SPS SPS SPS CPS
CPS CPS CPS CPS CPS CPS SGTCS
SGTCS SGTCS SGTCS SGTCS
Frequency of seizures per year SPS: 7000 SPS: 24–84 SPS: un SPS: un SPS: 24/a SPS: no CPS: <50/a
CPS: 6200 CPS: <6 CPS: 120/a CPS: 12/a CPS: 24/a CPS: 12/a SGTCS: 1/a
SGTCS: 2 SGTCS: un SGTCS: 24/a SGTCS: 1/35a
EEG ﬁndings at seizure onset Extended bilateral
diffuse amplitude
depression
Rhythmical 6/s theta
waves temporoposterior
right
Lafa temporobasal
and temporolateral
left
Rhythmic Delta
fronto centro
temporal left
Bitemporal rhythmic
delta activity
Rhythmical 7/s theta
activity temporoant
right (SP2)
Rhythmical activity
temporoant right
(SP2)
AED prior to monitoring [mg] CBZ 1200 CBZ 1600 VPA 900 TPM 1200 OXC 1800 LEV 1500 LEV 3000
PRI 125 LTG 300 VPA 600
CLB 5
ESL 1600
AED at time of asystole [mg] CBZ 1200 CBZ 1600 LTG 300 No AED OXC 1800 LEV 1500 LEV 4500
ESL 800 VPA 3300
Drug withdrawal No Yes Yes Yes No Yes Yes
SPS: simple partial seizures; CPS complex partial seizures, SGTCS secondary generalised tonic clonic seizures; Lafa: Low amplitude high frequency activity; AED antiepileptic drug; CBZ: Carbamazepine; CLB: Clobazam; PRI:
Primidone, LTG: Lamotrigine; LEV: Levetiracetam TPM: Topiramate; OXC: Oxcarbazepine; ESL: Eslicarbazepine; VPA: Valproate.
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Table 3
Cardiac status.
Patients
1 2 3 4 5 6 7
Interictal ECG Normal Normal Singular
extrasystoles
Left bundle
branch block
Normal Normal Postictal
bradycardia
Ictal ECG AV Block III Sinus arrest AV Block III AV Block III AV Block III Sinus arrest Sinus arrest
Duration of asystole [s] 3 and 6 25 35 34 29 77 5
ECG before and after asytole SR Tachyarrythmia/
bradyarrythmia
SR SR SR, bradycardia Tachyarrythmia/
bradyarryhtmia
Bradycardia/
tachycardia
Cardiovascular risk factors No No Essential
hypertonus
Essential
hypertonus
No No No
Time interval between seizure
onset (EEG) and onset of asystole
35 s after
seizure onset
229 s after
seizure onset
Un 3 s after
seizure onset
20 s after
seizure onset
37 s after
seizure onset
24 s after
seizure
ending
Flattening of electrical brain activity
before end of asystole
Yes Yes Yes Yes Yes Yes Yes
Pacemaker implantation Yes Yes Yes Yes Yes Yes No/event-
recorder
SR: sinus rhythm, un: unknown.
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patients.
After ictal asystole, 6 out of 7 obtained a cardiac pacemaker; in
the one patient having an postictal asystole an event recorder was
implanted; follow-up is still pending. There were no cases of death
during monitoring and no cases of SUDEP among the 7 patients
showing ictal asystole after a mean follow up of 5.6 years.
4. Discussion
In this large cohort, cardiac asystole occurred in 7 out of 2003
patients (0.34%). This is in line with the reported 0.27–0.4% of
patients suffering ictal asystole during prolonged video EEG
telemetry.15 It is of interest that the observed rate of 1 asystole
in 3.7 patient years is about at least ten times higher than the
incidence of SUDEP in pharmacoresistant epilepsy patients.16 In
particular, there was only one single case of SUDEP-like event
requiring cardiopulmonarly resuscitation during the 10.5-year
observation period and no SUDEP occurred during monitoring.
The frequency of asystole per patient year is similar to a report
of a small patient group undergoing long-term ambulatory ECG
monitoring.17 The authors found an incidence of asystole of 4 in 19
patients (16%) monitored for a median period of 18 months and a
total monitoring duration of 9167 patient days. It is of note that
under monitoring conditions, despite frequent changes in medi-
cation, similar frequencies of asystole per patient year were found,
whereas the patients monitored by Rugg-Gunn et al.17 may be
expected to have had more stable drug regimens.
MRI and EEGﬁndings emphasise the crucial role of the temporal
lobe in cardiovascular autonomic control.5 This is consistent with
reports that TLE surgery may reduce the incidence of SUDEP.18 It
has been discussed that there may be a preferential role of the left
hemisphere in the genesis of ictal bradycardia,19 and more
speciﬁcally of the left temporal lobe.12 So ictal bradycardia is
seen primarily in seizures involving the temporal lobe, but may
occur particularly with bilateral spread of ictal activity.10 In this
cohort, ictal asystole was about as frequent for seizures originating
from the left side as for seizures starting from the right side or
bilaterally. Two of the patients with right temporal seizure onset
showed a relevant tachycardia preceding the asystole, possibly due
to a higher sympathetic inﬂuence.13
Ictal asystole was not related to pre-existing cardiac disease.
None of the patients had ECG recordings which would have
required any type of treatment, and even long-term interictal ECG
recordings did not reveal a risk of asystole.Cardiacasystoles inourpatients lastedbetween3and77 sandall
patients had a ﬂattening of brain activity, suggesting cerebral
hypoxia, which has been considered a cofactor leading to death, but
we could not observed immediate onset of ﬂat EEG which would
support thehypothesiswhether SUDEP is causedby ‘‘electrical shut-
down of brain activity’’.20 There is insufﬁcient data available to
decide if brief periods of asystole are to be considered a benign
condition,21 or ifwidespread consequences to cerebral blood supply
may be a risk factor contributing to SUDEP-like events.
It is of interest that the clinical characteristics of the patients
having asystole in this study only partially overlap with commonly
assumed risk factors for developing SUDEP: only patients with
focal epilepsy had an asystole, ﬁve out of seven of these patients
had undergone reduction of medication,22 and two of them were
under treatment with carbamazepine.23,24
The fact that only patients with focal epilepsy showed ictal
asystole may point to pathophysiological aspects of cardiac
inﬂuences of epileptic activity, and correlates well with a shorter
life expectancy of patients particularly with focal epilepsy.25 In this
cohort, asystole did not occur during generalised tonic–clonic
seizures, which are considered a risk factor for SUDEP. Only four
patients had a long-lasting epilepsy and ﬁve were pharmacoresis-
tant2,17 at the time of evaluation, whereas asystole occurred also in
two patients with only 12–14 months of epilepsy duration. Four
patients with asystole were under monotherapy, whereas patients
underpolytherapy are considered to be at higher risk for SUDEP.26,17
The most severe case necessitating cardiopulmonary resuscita-
tion toprevent SUDEPhada long-lasting, parmacoresistant epilepsy,
an insular structural lesion, and was under polytherapy. However, a
lack of common risk factors in the patient history is not sufﬁcient to
exclude an individual risk for the occurrence of asystole.
Our data strongly suggest that not all patient suffering from
asystole will develop SUDEP, although in the individual patient
there are presently no criteria to predict which patients are at
particular risk. Multicentric analyses such as presently envisaged
in the Mortemus project27 may contribute to a better understand-
ing of the role of asystole in SUDEP in the future.
5. Conclusion
This retrospective monocentric analysis conﬁrms that ictal
related cardiac asystole is a rare event that occurred in seven out of
2003 patients with epilepsy in 9534monitored patient days. Those
patients had temporal lobe or insular epilepsy. A short duration of
epilepsy and normal evaluation of cardiac functions do not
preclude a risk of ictal asystole when experiencing complex focal
M. Lanz et al. / Seizure 20 (2011) 167–172172seizures with temporal involvement. Despite frequent changes in
the antiepileptic drug regimen, there were no SUDEP cases during
monitoring, but one patient who shared established risk factors
had to undergo cardiopulmonary resuscitation to prevent the
development of SUDEP.
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